E M Antman1. Show Affiliations » 1. Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA. eantman@rics.bwh.harvard.edu
Abstract
Entities: Chemical
Mesh: See more » Acute DiseaseAntithrombins/adverse effectsAntithrombins/therapeutic useClinical Trials as TopicCoronary Disease/drug therapyDalteparin/adverse effectsDalteparin/therapeutic useEnoxaparin/adverse effectsEnoxaparin/therapeutic useFibrinolytic Agents/adverse effectsFibrinolytic Agents/therapeutic useFollow-Up StudiesHeparin/therapeutic useHeparin, Low-Molecular-Weight/adverse effectsHeparin, Low-Molecular-Weight/therapeutic useHirudin TherapyHumansNadroparin/adverse effectsNadroparin/therapeutic useThrombin/antagonists & inhibitorsTime
Substances: See more » AntithrombinsEnoxaparinFibrinolytic AgentsHeparin, Low-Molecular-WeightNadroparinHeparinThrombinDalteparin
Year: 2001 PMID: 11342482 DOI: 10.1161/01.cir.103.18.2310
Source DB: PubMed Journal: Circulation ISSN: 0009-7322 Impact factor: 29.690